- GYRE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Gyre Therapeutics (GYRE) S-3Shelf registration
Filed: 16 Mar 16, 12:00am
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement of Catalyst Biosciences, Inc. on Form S-3 and prospectus supplement to be filed on or about March 16, 2016 of our report dated March 9, 2016, on our audits of the consolidated financial statements as of December 31, 2015 and 2014, and for each of the years in the three-year period ended December 31, 2015.
We also consent to the references to our firm under the caption “Experts” in the Registration Statement on Form S-3 and prospectus supplement.
/s/ EisnerAmper LLP
Iselin, New Jersey
March 16, 2016
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.